LYCOS RETRIEVER 
Hepatitis C: Treatments
built 255 days ago
In a study reported in the 1998 Journal of Traditional Chinese Medicine (4), 108 patients with hepatitis C were analyzed according to TCM. These patients had not used interferon (or had not had drug treatment for at least 6 months) or Chinese herbs (or had not had herbal treatment for at least 3 months). The proportion of males and females was relatively equal: 65 were male, 43 female, with an age range of 22-71 (average age 55). The high average age of this group, and the relatively more equal distribution among males and females correlates well with the proposal that the main risk factor is blood transfusion rather than "socializing." The patients were then evaluated and assigned into the five categories listed above, revealing:
Source:
Not everyone infected with the hepatitis C virus knows it. It's a tricky illness. It can be deadly. Information is crucial. The links below take you to this information. These to-the-point articles cover hepatitis C causes, symptoms, tests, and treatment. You'll ... find links to the support you'll need.
Source:
The medical reporting of treatments for hepatitis C in China has a number of flaws. Sometimes, the therapies (the herbal formulas) are not specified or only partially specified. Other times, the outcomes of treatment are unclear. Therefore, one should interpret the reports with some care.
Source:
Complementary therapies are used together with conventional medicine to treat many illnesses, including hepatitis C and the side effects of treatment. Complementary treatment attempts to use the body’s natural self-healing abilities to bring the body back into balance. See box at right for a short description of some complementary therapies.
Source:
The patients selected for treatment in this study (10) were suffering from aplastic anemia and had probably become infected by hepatitis C as the result of blood transfusions. The patients were treated for the anemia using 2 mg stanozol, three times daily (orally), and some patients received additional drugs for the anemia. Hepatitis C was treated according to differential diagnosis, with high-dosage herb combinations. As an example, for patients with symptoms such as pallor, lassitude, anorexia, nausea, abdominal fullness, and thin stools, the prescription included 25 grams pseudostellaria, 25 grams astragalus, 10 grams citrus, 10 grams tang-kuei, 12 grams cardamon, 20 grams peony, 20 grams bupleurum, 25 grams polygonatum, 20 grams coix, and 20 grams plantago seed. Patients ... received intravenous vitamins and other nutrient factors. Among 21 patients with hepatitis C, 17 were reportedly improved by the treatment, but only 4 had their hepatitis C antibody test turn negative.
Source:
SAN DIEGO, Oct. 27 /PRNewswire/ -- Idun Pharmaceuticals, Inc. today announced positive data from its oral dose-ranging clinical trial of IDN-6556 for the treatment of liver impairment caused by Hepatitis C virus (HCV) infection. The data showed that when given orally, IDN-6556 normalized liver enzymes after just two weeks of twice-a-day dosing. Increased levels of aminotransferase enzymes are a well-accepted indicator of damage in the liver. As was seen in an earlier trial with an intravenous form of IDN-6556, the drug was safe and well tolerated, and did not appear to exacerbate the HCV infection. The data was presented by Paul Pockros, M.D., Head of the Division of Gastroenterology and Hepatology at Scripps Clinic (San Diego), at a late- breaking session of the 54th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston.
Source:
MORE ABOUT
Treatments